Beijing Centergate Technologies (holding) Co., Ltd.
000931.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.46B
Close$
$3.85
11.8% downside
Current Fair Value
11.8% downsideOvervalued by 11.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.46 Billion |
|---|---|
| Enterprise Value | $4.51 Billion |
| Dividend Yield | $0.02 (0.44%) |
| Earnings per Share | $0.06 |
| Beta | 0.33 |
| Outstanding Shares | 753,126,982 |
Return
| Return on Equity | -1.30% |
|---|---|
| Return on Assets | -0.53% |
| Return on Invested Capital | 3.28% |
Valuation & Multiples
| P/E Ratio | -166.91 |
|---|---|
| PEG | 105.14 |
| Price to Sales | 2.18 |
| Price to Book Ratio | 2.18 |
| Enterprise Value to Revenue | 2.04 |
| Enterprise Value to EBIT | 55.73 |
| Enterprise Value to Net Income | -218 |
| Total Debt to Enterprise | 0.27 |
| Debt to Equity | 0.77 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 21, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
October 30, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Beijing Centergate Technologies (holding) Co., Ltd.
2,267 employees
CEO: Zhanjun Hou Beijing Centergate Technologies (holding) Co., Ltd. is a multifaceted corporation with a presence in both domestic Chinese and international markets. Its principal activities include the manufacturing and distribution of pharmaceuticals,...